Immune-regulatory networks and disease initiation

A07

Role of IL-6 in shaping local immune milieus in the CNS

Univ.-Prof. Dr. rer. nat. Ari Waisman
Institut für Molekulare Medizin, Forschungszentrum Immuntherapie
Mainz

Univ.-Prof. Dr.med. Thomas Korn
Neurologische Universitätsklinik
TU München

 

A09

Analysis and therapeutic modifications of innate immune regulatory networks in controlling T-cell activation in MS

Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

Dr. rer. nat. Catharina Groß
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

 

A11

MOG Antibody-Induced CNS Demyelination: from Specificity to Function

Prof. Dr. med. Edgard Meinl
Institut für klinische Neuroimmunologie
LMU München

Univ.-Prof.Dr. med. Jan Lünemann
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

 

A12

Provenance mapping of immune cells in the CSF

Univ.-Prof. Dr. med. Thomas Korn
Klinik für Neurologie
TU München

Priv.-Doz. Dr. med. Klaus Lehmann-Horn
Klinik für Neurologie
TU München

 

B04

Unraveling the role of myeloid cells and metabolism in clinical progression of MS

Prof. Dr. med. Stefan Bittner
Klink für Neurologie, Forschungszentrum Immuntherapie
Mainz

Univ.-Prof. Dr. rer. nat. Tobias Bopp
Institut für Immunologie, Forschungszentrum Immuntherapie
Mainz

 

B08

B cells and B cell directed therapies in CNS inflammation

Prof. Dr. med. Edgar Meinl
Institut für Klinische Neuroimmunologie
LMU München

Dr. rer nat. Anneli Peters (née Jäger)
Institut für Klinische Neuroimmunologie
LMU München

News

Thu, 15/09/2022
Photo gallery: Inflammation & Imaging Symposium in the MIC building
Muenster. From September 12th to 14th scientists from Muenster University and their international guests discussed the latest developments in research on inflammation and the imaging of the immune system at the 2nd Inflammation & Imaging Symposium. The annual event is jointly organised by several research networks from Münster, among them the CRC/TRR 128 “Multiple Sclerosis”. […]...more
Tue, 28/06/2022
CRC Retreat in Münster
Muenster. After a long pause, more than 90 participants of the CRC joined in Muenster Factory Hotel to update on the latest developments. We heard the most recent on a selection of the CRC projects and there was also plenty of time for fruitful discussion and socializing in the evening....more
Mon, 23/05/2022
EU Research Council awards Lydia Sorokin Advanced Grant
Münster – The biochemist and Principal investigator of the CRC 128 Prof. Dr. Lydia Sorokin has received the coveted “Advanced Grant” awarded by the European Research Council (ERC). The funding of ca. 2.3 million euros enables the realisation of outstanding research projects. Lydia Sorokin heads the Institute for Physiological Chemistry and Pathobiochemistry at Muenster University. […]...more